RODRIGUEZ-GALAN, Ana, Sara G DOSIL, Anna VLČKOVÁ, Lola FERNANDEZ-MESSINA, Zuzana FEKETOVÁ, Julie POKORNÁ, Irene FERNANDEZ-DELGADO, Emilio CAMAFEITA, Manuel Jose GOMEZ, Marta RAMIREZ-HUESCA, Cristina GUTIERREZ-VAZQUEZ, Fatima SANCHEZ-CABO, Jesus VAZQUEZ, Štěpánka VAŇÁČOVÁ and Francisco SANCHEZ-MADRID. ISG20L2: an RNA nuclease regulating T cell activation. Cellular and molecular life sciences. BASEL: BIRKHAUSER VERLAG AG, 2023, vol. 80, No 9, p. 1-19. ISSN 1420-682X. Available from: https://dx.doi.org/10.1007/s00018-023-04925-2.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name ISG20L2: an RNA nuclease regulating T cell activation
Authors RODRIGUEZ-GALAN, Ana, Sara G DOSIL, Anna VLČKOVÁ (203 Czech Republic, belonging to the institution), Lola FERNANDEZ-MESSINA, Zuzana FEKETOVÁ (703 Slovakia, belonging to the institution), Julie POKORNÁ (203 Czech Republic, belonging to the institution), Irene FERNANDEZ-DELGADO, Emilio CAMAFEITA, Manuel Jose GOMEZ, Marta RAMIREZ-HUESCA, Cristina GUTIERREZ-VAZQUEZ, Fatima SANCHEZ-CABO, Jesus VAZQUEZ, Štěpánka VAŇÁČOVÁ (203 Czech Republic, belonging to the institution) and Francisco SANCHEZ-MADRID (guarantor).
Edition Cellular and molecular life sciences, BASEL, BIRKHAUSER VERLAG AG, 2023, 1420-682X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 8.000 in 2022
RIV identification code RIV/00216224:14740/23:00133564
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1007/s00018-023-04925-2
UT WoS 001058609400002
Keywords in English Exonuclease; T cell; Immunoregulatory
Tags 14110513, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 26/4/2024 13:22.
Abstract
ISG20L2, a 3' to 5' exoribonuclease previously associated with ribosome biogenesis, is identified here in activated T cells as an enzyme with a preferential affinity for uridylated miRNA substrates. This enzyme is upregulated in T lymphocytes upon TCR and IFN type I stimulation and appears to be involved in regulating T cell function. ISG20L2 silencing leads to an increased basal expression of CD69 and induces greater IL2 secretion. However, ISG20L2 absence impairs CD25 upregula-tion, CD3 synaptic accumulation and MTOC translocation towards the antigen-presenting cell during immune synapsis. Remarkably, ISG20L2 controls the expression of immunoregulatory molecules, such as AHR, NKG2D, CTLA-4, CD137, TIM-3, PD-L1 or PD-1, which show increased levels in ISG20L2 knockout T cells. The dysregulation observed in these key molecules for T cell responses support a role for this exonuclease as a novel RNA-based regulator of T cell function.
Links
GA20-19617S, research and development projectName: Molekulární mechanismy nekanonických 3' terminálních modifikací RNA a jejich úloha v metabolismu kódujících a nekódujících RNA
Investor: Czech Science Foundation
GA23-07372S, research and development projectName: Identifikace a úloha proteinů v kontrole a degradaci RNA a regulaci genové exprese
Investor: Czech Science Foundation, Identification and role of proteins in control and degradation of RNA and regulation of gene expression
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 17/7/2024 16:36